HOME › DRUGS › SACITUZUMAB GOVITECAN
ACTIVE SUBSTANCE / INN

SACITUZUMAB GOVITECAN

Brand name(s): Trodelvy
EMA LISTED
AUTHORISED
Breast Neoplasms;Triple Negative Breast Neoplasms
ACTIVE SUBSTANCE
Sacituzumab Govitecan
REGULATORS
EMA
SPONSORS / MAH
Gilead Sciences Ireland UC
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TrodelvyGilead Sciences Ireland UCAuthorised22/11/2021Breast Neoplasms;Triple Negative Breast Neoplasms

FULL INTELLIGENCE ON SACITUZUMAB GOVITECAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →